# IRBESARTAN AND HYDROCHLOROTHIAZIDE
> **ANDA077969** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2016-07-20
## Drug
- **FDA Application Number:** ANDA077969
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IRBESARTAN AND HYDROCHLOROTHIAZIDE
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; IRBESARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2016-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077969)
---
*AI Analytics · CC0 1.0*